Paige Predict

AI-powered digital pathology for biomarker prediction from H&E images.

by Tempus AI · Drug Discovery AI

Executive Summary

Paige Predict is an advanced AI-powered digital pathology solution developed by Tempus AI. It is designed to analyze digitized images of H&E-stained pathology slides to predict the presence of genomic and phenotypic biomarkers. This capability is particularly valuable in scenarios where tissue samples are limited, enabling clinicians and researchers to gain rapid access to crucial insights without the need for additional invasive procedures or extensive sample processing. The solution leverages sophisticated AI models to forecast tissue nucleic acid (TNA) yield, which helps identify samples at risk of Next-Generation Sequencing (NGS) failure. By providing these predictions, Paige Predict helps optimize the use of precious tissue samples, streamline diagnostic workflows, and accelerate research into precision medicine. It transforms raw pathology images into actionable intelligence, advancing biomarker screening at scale.

Use Cases

  • Predicting genomic and phenotypic biomarker presence from H&E images.
  • Forecasting tissue nucleic acid (TNA) yield to assess sample quality.
  • Identifying tissue samples at risk of Next-Generation Sequencing (NGS) failure.
  • Guiding treatment decisions and research when tissue samples are limited.
  • Advancing biomarker screening at scale in oncology and other fields.

Features

Intelligence

  • AI-Powered Biomarker Prediction: Analyzes H&E whole slide images to predict genomic and phenotypic biomarker presence.
  • Tissue Nucleic Acid (TNA) Yield Forecasting: Forecasts TNA yield to identify samples at risk of NGS failure, optimizing sample use.
  • Digital Pathology Analysis: Transforms digitized H&E slides into actionable insights for precision medicine.

Technical Specifications

Architecture
AI system that analyzes digitized images, implying a cloud-based processing architecture.
Deployment
SaaS

Integrations

  • EHR/EMR Systems

Pricing

Starting Price
Contact sales
Target Customer
Enterprise
Contract Type
Annual

About Tempus AI

Tempus AI is a healthcare technology company that leverages data and artificial intelligence to provide precision medicine services, including diagnostics, for various therapeutic areas such as oncology, cardiology, radiology, and depression. The company has built one of the world's largest libraries of clinical and molecular data, along with an operating system to make this data accessible and useful for personalized patient care and accelerating therapeutic discovery.

Founded: 2015 · Headquarters: Chicago, United States · Employees: 1000+ · Public